| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,605,039 | 3,813,519 | 3,187,013 | | Cost of Revenue | 1,148,562 | 927,330 | 735,671 | | | Gross Profit | 3,456,477 | 2,886,189 | 2,451,342 | | | Operating Expenses | | Research Development | 1,308,330 | 737,685 | 649,951 | | Selling General and Administrative | 1,338,190 | 1,187,184 | 1,010,400 | | Non Recurring | 2,036 | 106,350 | 772,145 | | Others | 226,442 | 201,105 | 209,355 | | | | Total Operating Expenses | 2,874,998 | 2,232,324 | 2,641,851 | | | | Operating Income or Loss | 581,479 | 653,865 | (190,509) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 46,059 | 90,024 | 53,956 | | Earnings Before Interest And Taxes | 629,956 | 747,821 | (37,200) | | Interest Expense | 4,418 | 12,147 | 15,478 | | Income Before Tax | 625,538 | 735,674 | (52,678) | | Income Tax Expense | 204,457 | 255,481 | (35,881) | | Minority Interest | 2,217 | 3,932 | 10,418 | | | | Net Income From Continuing Ops | 421,081 | 480,193 | (16,797) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 421,081 | 480,193 | (16,797) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $421,081 | $480,193 | ($16,797) |
|
0.16% Nasdaq 0.00%
Income Statement
